GUBMENTPlain talk · policy frontier
Filings / Drugs / Sources / §14 CM legal-status correction
GBMT-8 · Research record · No. 8

§14 CM legal-status correction

drugs/research/ws14-cm-legal-status.md
This is a working research document from the drugs filing, published as written — including the parts later corrected. It is the underlying record for Whitepaper No. 8, not a summary of it.

Date: 2026-08-06. This primary-source correction supersedes any statement that CM has a settled nationwide safe-harbor expansion or an OIG $75 “cap.”

The currently executable payment paths are SAMHSA grant programmes and state-specific Medicaid coverage (including selected §1115 approvals). A future federal safe harbor is prospective and uncertain. Any later score must split those paths from CM's clinical-efficacy evidence.

← All Drugs research documents Sources digest Read the whitepaper